莱索托农村VIBRA整群随机试验:村卫生员续药与诊所随访对比
VIBRA在莱索托249个农村村庄开展整群随机优效试验,比较家庭同日启动ART后由村卫生员续药与诊所续药。12个月病毒抑制率干预组39%、对照组46%,调整风险差-0.07(95%CI -0.20至0.06;p=0.256),两组结局相似,干预未放大同日启动ART的效果。
要点
- 家庭同日启动ART后村卫生员续药与诊所续药12个月病毒抑制率无显著差异。
- 干预组仅41%(48/118)选择村卫生员续药,未选择者中59%(41/70)提及信任或冲突问题。
- 研究提示对社区启动后由非专业卫生员提供ART的接受度和安全性需关注。
核心结论
- 家庭同日启动ART后提供村卫生员续药与诊所续药结局相似,干预未放大同日启动ART本身的效果。
- 研究结果引发对社区启动后由非专业卫生员提供ART的接受度和安全性的担忧。
研究设计与样本
- VIBRA为在莱索托两个区20家卫生机构服务区249个农村村庄开展的整群随机开放标签临床优效性试验。
- 干预村在挨家挨户HIV检测中发现HIV阳性者提供同日ART启动及村卫生员续药选项,对照村提供同日启动及诊所续药。
- 主要结局为12个月病毒抑制,次要终点包括 linkage 和12个月参与照护,采用意向性分析。
主要发现
- 12个月病毒抑制:干预组46/118(39%),对照组64/139(46%),调整风险差-0.07(95%CI -0.20至0.06;p=0.256)。
- linkage 两组相似,调整风险差0.03(95%CI -0.10至0.16;p=0.630)。
- 参与照护干预组非显著更低,调整风险差-0.12(95%CI -0.23至0.003;p=0.058)。
- 干预组与对照组分别发生7例和0例死亡。
- 干预组入组时未选择村卫生员续药者中,41/70(59%)提及信任或冲突问题为主要原因。
临床怎么用
- 在资源有限地区,家庭同日启动ART后村卫生员续药可作为诊所续药的替代选择之一,但需关注信任与冲突问题对接受度的影响。
局限性
- 样本量较小。
- 主要终点窗口期有9%病毒载量测量缺失。
- 干预组村卫生员续药选项接受度低。
- 研究人群迁移比例较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Community-based antiretroviral therapy (ART) dispensing by lay workers is an important differentiated service delivery model in sub-Sahara Africa. However, patients new in care are generally excluded from such models. Home-based same-day ART initiation is becoming widespread practice, but linkage to the clinic is challenging. The pragmatic VIBRA (Village-Based Refill of ART) trial compared ART refill by existing lay village health workers (VHWs) versus clinic-based refill after home-based same-day ART initiation. METHODS AND FINDINGS: The VIBRA trial is a cluster-randomized open-label clinical superiority trial conducted in 249 rural villages in the catchment areas of 20 health facilities in 2 districts (Butha-Buthe and Mokhotlong) in Lesotho. In villages (clusters) randomized to the intervention arm, individuals found to be HIV-positive during a door-to-door HIV testing campaign were offered same-day ART initiation with the option of refill by VHWs. The trained VHWs dispensed drugs and scheduled clinic visits for viral load measurement at 6 and 12 months. In villages randomized to the control arm, participants were offered same-day ART initiation with clinic-based ART refill. The primary outcome was 12-month viral suppression. Secondary endpoints included linkage and 12-month engagement in care. Analyses were intention-to-treat. The trial was registered on ClinicalTrials.gov (NCT03630549). From 16 August 2018 until 28 May 2019, 118 individuals from 108 households in 57 clusters in the intervention arm, and 139 individuals from 130 households in 60 clusters in the control arm, were enrolled (150 [58%] female; median age 36 years [interquartile range 30-48]; 200 [78%] newly diagnosed). In the intervention arm, 48/118 (41%) opted for VHW refill. At 12 months, 46/118 (39%) participants in the intervention arm and 64/139 (46%) in the control arm achieved viral suppression (adjusted risk difference -0.07 [95% CI -0.20 to 0.06]; p = 0.256). Arms were similar in linkage (adjusted risk difference 0.03 [-0.10 to 0.16]; p = 0.630), but engagement in care was non-significantly lower in the intervention arm (adjusted risk difference -0.12 [-0.23 to 0.003]; p = 0.058). Seven and 0 deaths occurred in the intervention and control arm, respectively. Of the intervention participants who did not opt for drug refill from the VHW at enrollment, 41/70 (59%) mentioned trust or conflict issues as the primary reason. Study limitations include a rather small sample size, 9% missing viral load measurements in the primary endpoint window, the low uptake of the VHW refill option in the intervention arm, and substantial migration among the study population. CONCLUSIONS: The offer of village-based ART refill after same-day initiation led to similar outcomes as clinic-based refill. The intervention did not amplify the effect of home-based same-day ART initiation alone. The findings raise concerns about acceptance and safety of ART delivered by lay health workers after initiation in the community. TRIAL REGISTRATION: Registered with Clinicaltrials.gov (NCT03630549).
引用
- Amstutz A, Lejone TI, Khesa L, et al. Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial. PLoS Med. 2021. PMID: 34673765. doi:10.1371/journal.pmed.1003839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。